GLP-1 Medications Show Potential for Improving Male Fertility Markers
Preliminary research suggests a possible link between GLP-1 drugs and improved testosterone, sperm count, and sperm shape in men with obesity — but experts warn that more studies are needed before clinical recommendations can be made.
Key Findings from Studies
Research presented at the Endocrine Society's annual meeting and the American Urological Association meeting examined the effects of GLP-1 drugs on male reproductive health.
Systematic Review
A review of five randomized controlled trials, presented by Dr. Pratibha Natesh of University Hospitals Coventry and Warwickshire, found that men aged 18-65 taking GLP-1 medications for 24 weeks showed improved testosterone levels, sperm count, and sperm morphology.
Specific Trial Data
-
A 16-week study of 30 men with obesity and low testosterone (hypogonadism) found that testosterone levels increased similarly in those receiving a GLP-1 drug and those receiving testosterone replacement therapy (TRT).
-
A 24-week study of 25 men with type 2 diabetes and hypogonadism reported that testosterone increased in both treatment groups (more with TRT). However, sperm quality improved only in the GLP-1 group, where the percentage of normal-shaped sperm rose from 2% to 4%. The TRT group experienced declines in sperm count and quality.
-
Three additional studies involving healthy men given GLP-1 drugs for short periods showed no effect on testosterone levels.
Analysis of Prescription Data
An analysis of over 1,600 men prescribed obesity drugs, presented at the American Urological Association meeting, found that participants' testosterone levels increased by approximately 30% after treatment with GLP-1 drugs or drugs mimicking GLP-1 and glucose-dependent insulinotropic polypeptide.
Expert Commentary and Caveats
Medical experts have noted several points of context regarding the findings.
Dr. Natesh suggested that weight loss resulting from GLP-1 use may improve hormone function and that the drugs could offer an alternative to testosterone replacement therapy, which can suppress sperm production.
Dr. Amin Herati from Johns Hopkins Hospital emphasized the importance of a fertility evaluation and noted that sudden weight loss may signal the body that it is not a safe time to reproduce, which could potentially limit fertility.
Dr. Lidia Mínguez Alarcón from Brigham and Women's Hospital stated that the results suggest potential benefits but require further investigation.
All experts consulted stated that the evidence is preliminary and that more robust, standardized trials are needed to confirm the association between GLP-1 drugs and improved fertility.
Background and Context
GLP-1 medications are primarily prescribed for the management of type 2 diabetes and weight loss. According to Yale Medicine, approximately 15% of couples in the United States experience infertility, with over half of cases related to male factors.
General recommendations for improving male fertility include:
- Limiting ultraprocessed foods
- Engaging in regular exercise
- Reducing sedentary behavior
- Avoiding excessive heat exposure
- Reducing smoking and alcohol consumption
Men seeking to conceive are advised to inform their healthcare providers to consider appropriate treatment options.